ClinVar Miner

Submissions for variant NM_000218.3(KCNQ1):c.1343del (p.Pro448fs)

dbSNP: rs397508087
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV001841630 SCV000234584 pathogenic Cardiac arrhythmia 2013-09-25 criteria provided, single submitter clinical testing The c.1343delC mutation in the KCNQ1 gene has been reported in association with LQTS (Neyroud N et al., 1999). Neyroud et al. identified c.1343delC in two affected individuals with LQTS from one family. This mutation causes a shift in reading frame starting at codon Proline 448, changing it to a Glutamine, and creating a premature stop codon at position 18 of the new reading frame, denoted p.Pro448GlnfsX18. This mutation is expected to result in either an abnormal, truncated protein product or loss of protein from this allele through nonsense-mediated mRNA decay. Other frameshift mutations in the KCNQ1 gene have been reported in association with LQTS. Finally, the c.1343delC mutation was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The variant is found in LQT panel(s).
Invitae RCV001380029 SCV001577956 pathogenic Long QT syndrome 2023-05-25 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 52977). This premature translational stop signal has been observed in individual(s) with long QT syndrome (PMID: 10024302). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Pro448Glnfs*18) in the KCNQ1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KCNQ1 are known to be pathogenic (PMID: 9323054, 19862833).
Ambry Genetics RCV002381341 SCV002688776 pathogenic Cardiovascular phenotype 2021-12-16 criteria provided, single submitter clinical testing The c.1343delC pathogenic mutation, located in coding exon 10 of the KCNQ1 gene, results from a deletion of one nucleotide at nucleotide position 1343, causing a translational frameshift with a predicted alternate stop codon (p.P448Qfs*18). This mutation has been reported in association with long QT syndrome (Neyroud N et al. Circ Res, 1999 Feb;84:290-7; Walsh R et al. Genet Med, 2021 01;23:47-58). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Molecular Genetics Laboratory - Cardiogenetics, CHU de Nantes RCV003319306 SCV004024167 pathogenic Long QT syndrome 1 2023-08-01 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.